相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bacterial siderophores in community and host interactions
Jos Kramer et al.
NATURE REVIEWS MICROBIOLOGY (2020)
Lipocalin-2 expression and function in pancreatic diseases
Kristyn Gumpper et al.
PANCREATOLOGY (2020)
Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview
Subha Mondal et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Circulating levels of lipocalin-2 are associated with fatty pancreas but not fatty liver
Ruma G. Singh et al.
PEPTIDES (2019)
Therapeutic genome editing of triple-negative breast tumors using a noncationic and deformable nanolipogel
Peng Guo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
CRABP1, C1QL1 and LCN2 are biomarkers of differentiated thyroid carcinoma, and predict extrathyroidal extension
Ricardo Celestino et al.
BMC CANCER (2018)
Lipocalin 2 regulates retinoic acid-induced activation of beige adipocytes
Jessica A. Deis et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2018)
NGAL is Downregulated in Oral Squamous Cell Carcinoma and Leads to Increased Survival, Proliferation, Migration and Chemoresistance
Javadi Monisha et al.
CANCERS (2018)
Loss of the adipokine lipocalin-2 impairs satellite cell activation and skeletal muscle regeneration
Irena A. Rebalka et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2018)
Iron and Cancer
Suzy V. Torti et al.
ANNUAL REVIEW OF NUTRITION, VOL 38 (2018)
LCN2 overexpression in bone enhances the hematopoietic compartment via modulation of the bone marrow microenvironment
Delfina Costa et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2017)
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2017)
Lipocalin-2: A Master Mediator of Intestinal and Metabolic Inflammation
Alexander R. Moschen et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2017)
Iron Handling in Tumor-Associated Macrophages-Is There a New Role for Lipocalin-2?
Michaela Jung et al.
FRONTIERS IN IMMUNOLOGY (2017)
Lipocalin-2 Promotes Pancreatic Ductal Adenocarcinoma by Regulating Inflammation in the Tumor Microenvironment
Sobeyda B. Gomez-Chou et al.
CANCER RESEARCH (2017)
Roles of NGAL and MMP-9 in the tumor microenvironment and sensitivity to targeted therapy
Saverio Candido et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
EMT, cell plasticity and metastasis
Christine L. Chaffer et al.
CANCER AND METASTASIS REVIEWS (2016)
Tumour stroma-derived lipocalin-2 promotes breast cancer metastasis
Bilge Oeren et al.
JOURNAL OF PATHOLOGY (2016)
ICAM-1-Targeted, Lcn2 siRNA-Encapsulating Liposomes are Potent Anti-angiogenic Agents for Triple Negative Breast Cancer
Peng Guo et al.
THERANOSTICS (2016)
Lipocalin 2 Enhances Migration and Resistance against Cisplatin in Endometrial Carcinoma Cells
Tsutomu Miyamoto et al.
PLOS ONE (2016)
Lipocalin 2 (LCN2) is a promising target for cholangiocarcinoma treatment and bile LCN2 level is a potential cholangiocarcinoma diagnostic marker
Kun-Chun Chiang et al.
SCIENTIFIC REPORTS (2016)
Lipocalin-2 and matrix metalloproteinase-9 expression in high-grade endometrial cancer and their prognostic value
Sanja Srdelic Mihalj et al.
HISTOPATHOLOGY (2015)
The ligands of neutrophil gelatinase-associated lipocalin
Guan-Hu Bao et al.
RSC ADVANCES (2015)
Selective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal Cancer
Derek C. Marshall et al.
PLOS ONE (2015)
Lipocalin-2 Protein Deficiency Ameliorates Experimental Autoimmune Encephalomyelitis THE PATHOGENIC ROLE OF LIPOCALIN-2 IN THE CENTRAL NERVOUS SYSTEM AND PERIPHERAL LYMPHOID TISSUES
Youngpyo Nam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Regulation of mammalian siderophore 2,5-DHBA in the innate immune response to infection
Zhuoming Liu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Inhibiting Metastatic Breast Cancer Cell Migration via the Synergy of Targeted, pH-triggered siRNA Delivery and Chemokine Axis Blockade
Peng Guo et al.
MOLECULAR PHARMACEUTICS (2014)
ICAM-1 as a molecular target for triple negative breast cancer
Peng Guo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Up-regulation of Neutrophil Gelatinase-Associated Lipocalin in Colorectal Cancer Predicts Poor Patient Survival
Herbert Thomas Maier et al.
WORLD JOURNAL OF SURGERY (2014)
C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment
Nissar Ahmad Wani et al.
BREAST CANCER RESEARCH (2014)
Lipocalin 2 is a novel regulator of angiogenesis in human breast cancer
Jiang Yang et al.
FASEB JOURNAL (2013)
Lipocalin-2 is associated with radioresistance in oral cancer and lung cancer cells
Masashi Shiiba et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Bim, a Proapoptotic Protein, Up-regulated via Transcription Factor E2F1-dependent Mechanism, Functions as a Prosurvival Molecule in Cancer
Raghu Gogada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
NGAL Controls the Metastatic Potential of Anaplastic Thyroid Carcinoma Cells
Vincenzo Volpe et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Neutrophil Gelatinase-Associated Lipocalin, Macrophage Inhibitory Cytokine 1, and Carbohydrate Antigen 19-9 in Pancreatic Juice Pathobiologic Implications in Diagnosing Benign and Malignant Disease of the Pancreas
Sukhwinder Kaur et al.
PANCREAS (2013)
Potentials of Plasma NGAL and MIC-1 as Biomarker(s) in the Diagnosis of Lethal Pancreatic Cancer
Sukhwinder Kaur et al.
PLOS ONE (2013)
Knockdown of lipocalin-2 suppresses the growth and invasion of prostate cancer cells
Min-Che Tung et al.
PROSTATE (2013)
Iron and cancer: more ore to be mined
Suzy V. Torti et al.
NATURE REVIEWS CANCER (2013)
The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer
Subhankar Chakraborty et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2012)
Lipocalin 2 expression is associated with aggressive features of endometrial cancer
Monica Mannelqvist et al.
BMC CANCER (2012)
Small lipid-binding proteins in regulating endothelial and vascular functions: focusing on adipocyte fatty acid binding protein and lipocalin-2
Yu Wang
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Lipocalin2 Promotes Invasion, Tumorigenicity and Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma
Lisa Leung et al.
PLOS ONE (2012)
Alginate: Properties and biomedical applications
Kuen Yong Lee et al.
PROGRESS IN POLYMER SCIENCE (2012)
Immunohistochemical detection of a specific receptor for lipocalin2 (solute carrier family 22 member 17, SLC22A17) and its prognostic significance in endometrial carcinoma
Tsutomu Miyamoto et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2011)
Inhibition of the proliferation and invasion of hepatocellular carcinoma cells by lipocalin 2 through blockade of JNK and PI3K/Akt signaling
Eun-Kyoung Lee et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2011)
Relationships of Lipocalin 2 With Breast Tumorigenesis and Metastasis
Xiaohong Leng et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
Up-regulation of neutrophil gelatinase-associated lipocalin in oral squamous cell carcinoma: Relation to cell differentiation
Takashi Hiromoto et al.
ONCOLOGY REPORTS (2011)
A Mammalian Siderophore Synthesized by an Enzyme with a Bacterial Homolog Involved in Enterobactin Production
Laxminarayana R. Devireddy et al.
CELL (2010)
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kai Kessenbrock et al.
CELL (2010)
Neutrophil Gelatinase-Associated Lipocalin induces the expression of heme oxygenase-1 and superoxide dismutase 1, 2
Parisa Bahmani et al.
CELL STRESS & CHAPERONES (2010)
NGAL knockdown by siRNA in human cholangiocarcinoma cells suppressed invasion by reducing NGAL/MMP-9 complex formation
Chalinee Nuntagowat et al.
CLINICAL & EXPERIMENTAL METASTASIS (2010)
Lipocalin-2 Deficiency Attenuates Insulin Resistance Associated With Aging and Obesity
Ivy K. M. Law et al.
DIABETES (2010)
Induction of Neutrophil Gelatinase-associated Lipocalin Expression by Co-stimulation with Interleukin-17 and Tumor Necrosis Factor-α Is Controlled by IκB-ζ but neither by C/EBP-β nor C/EBP-δ
Joachim R. Karlsen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Iron traffics in circulation bound to a siderocalin (Ngal)-catechol complex
Guanhu Bao et al.
NATURE CHEMICAL BIOLOGY (2010)
Inhibition of Lipocalin 2 Impairs Breast Tumorigenesis and Metastasis
Xiaohong Leng et al.
CANCER RESEARCH (2009)
Lipocalin 2 promotes breast cancer progression
Jiang Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Neutrophil gelatinase-associated lipocalin acts as a protective factor against H2O2 toxicity
Mehryar Habibi Roudkenar et al.
ARCHIVES OF MEDICAL RESEARCH (2008)
Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia
N. Moniaux et al.
BRITISH JOURNAL OF CANCER (2008)
Neutrophil gelatinase-associated lipocalin: A novel suppressor of invasion and angiogenesis in pancreatic cancer
Zhimin Tong et al.
CANCER RESEARCH (2008)
Tumor-Specific Urinary Matrix Metalloproteinase Fingerprinting: Identification of High Molecular Weight Urinary Matrix Metalloproteinase Species
Roopali Roy et al.
CLINICAL CANCER RESEARCH (2008)
Lipocalin 2 promotes lung metastasis of murine breast cancer cells
Han Shi et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2008)
The neutrophil gelatinase-associated lipocalin (NGAL), a NF-κB-regulated gene, is a survival factor for thyroid neoplastic cells
Alessio Lannetti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer
Maret Bauer et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer
Frank J. G. M. Kubben et al.
EUROPEAN JOURNAL OF CANCER (2007)
Dual action of neutrophil gelatinase-associated lipocalin
Kai M. Schmidt-Ott et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Oxidative stress induced lipocalin 2 gene expression: Addressing its expression under the harmful conditions
Mehryar Habibi Roudkenar et al.
JOURNAL OF RADIATION RESEARCH (2007)
Ectopic expression of neutrophil gelatinase-associated lipocalin suppresses the invasion and liver metastasis of colon cancer cells
HJ Lee et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake
LR Devireddy et al.
CELL (2005)
The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients
CA Fernández et al.
CLINICAL CANCER RESEARCH (2005)
Siderocalin (Lcn 2) also binds carboxymycobactins, potentially defending against mycobacterial infections through iron sequestration
MA Holmes et al.
STRUCTURE (2005)
Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis
E Missiaglia et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
An iron delivery pathway mediated by a lipocalin
J Yang et al.
MOLECULAR CELL (2002)
The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition
DH Goetz et al.
MOLECULAR CELL (2002)
New functions for the matrix metalloproteinases in cancer progression
M Egeblad et al.
NATURE REVIEWS CANCER (2002)
The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL) - Modulation of MMP-9 activity by NGAL
L Yan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The human neutrophil lipocalin supports the allosteric activation of matrix metalloproteinases
H Tschesche et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
The lipocalin protein family: structural and sequence overview
DR Flower et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY (2000)
分享论文
